Effect of a Reminder Statement on Echocardiography Reports on Referrals for Implantable Cardioverter-Defibrillators for Primary Prevention

American Journal of Cardiology

Volumn 119, Issue 3, 2017, Pages 478-482

  Chokshi, Moulin ^a   McNamara, Robert L ^a   Rajeswaran, Yasotha ^b   Lampert, Rachel ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LEHIGH VALLEY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; DEATH, SUDDEN, CARDIAC; DOCUMENTATION; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MIDDLE AGED; PROCEDURES; REMINDER SYSTEM; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; THERAPY; UTILIZATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DOCUMENTATION; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PRIMARY PREVENTION; REFERRAL AND CONSULTATION; REMINDER SYSTEMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 85007579649     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2016.10.018     Document Type: Article

References (18)

1. 1 Bardy, G.H., Lee, K.L., Mark, D.B., Poole, J.E., Packer, D.L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., McNulty, S.E., Clapp-Channing, N., Davidson-Ray, L.D., Fraulo, E.S., Fishbein, D.P., Luceri, R.M., Ip, J.H., Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005), 225–237.
2. 2 Moss, A.J., Zareba, W., Hall, W.J., Klein, H., Wilber, D.J., Cannom, D.S., Daubert, J.P., Higgins, S.L., Brown, M.W., Andrews, M.L., Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002), 877–883.
3. 3 Epstein, A.E., DiMarco, J.P., Ellenbogen, K.A., Estes, N.A. III, Freedman, R.A., Gettes, L.S., Gillinov, A.M., Gregoratos, G., Hammill, S.C., Hayes, D.L., Hlatky, M.A., Newby, L.K., Page, R.L., Schoenfeld, M.H., Silka, M.J., Stevenson, L.W., Sweeney, M.O., 2012 ACCF/AHA/HRS Focused Update Incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac Rhythm Abnormalities. Circulation 127 (2013), e283–e352.
4. 4 Shah, B., Hernandez, A.F., Liang, L., Al-Khatib, A.L., Yancy, C.W., Fonarow, G.C., Peterson, E.D., Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF registry. J Am Coll Cardiol 53 (2009), 416–422.
5. 5 Ruskin, J.N., Camm, A.J., Zipes, D.P., Hallstrom, A.P., McGrory-Usset, M.E., Implantable cardioverter defibrillator utilization based on discharge diagnoses from Medicare and managed care patients. J Cardiovasc Electrophysiol 13 (2002), 38–43.
6. 6 Voigt, A., Ezzeddine, R., Barrington, W., Obiaha-Ngwu, O., Ganz, L.I., London, B., Saba, S., Utilization of implantable cardioverter-defibrillators in survivors of cardiac arrest in the United States from 1996 to 2001. J Am Coll Cardiol 44 (2004), 855–858.
7. 7 Bradfield, J., Warner, A., Bersohn, M.M., Low referral rate for prophylactic implantation of cardioverter-defibrillators in a tertiary care medical center. Pacing Clin Electrophysiol 32:Suppl 1 (2009), S194–S197.
8. 8 Gravelin, L.M., Yuhas, J., Remetz, M., Radford, M., Foley, J., Lampert, R., Use of a screening tool improves appropriate referral to an electrophysiologist for implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. Circ Cardiovasc Qual Outcomes 4 (2011), 152–156.
9. 9 Chen, T.H., Wo, H.T., Chang, P.C., Wang, C.C., Wen, M.S., Chou, C.C., A meta-analysis of mortality in end-stage renal disease patients receiving implantable cardioverter defibrillators (ICDs). PLoS One, 9, 2014, e99418.
10. 10 Hess, P.L., Hellkamp, A.S., Peterson, E.D., Sanders, G.D., Al-Khalidi, H.R., Curtis, L.H., Hammill, B.G., Pun, P.H., Curtis, J.P., Anstrom, K.J., Hammill, S.C., Al-Khatib, S.M., Survival after primary prevention implantable cardioverter-defibrillator placement among patients with Chronic Kidney disease. Circ Arrhythm Electrophysiol 7 (2014), 793–799.
11. 11 Steinberg, B.A., Al-Khatib, S.M., Edwards, R., Han, J., Bardy, G.H., Bigger, J.T., Buxton, A.E., Moss, A.J., Lee, K.L., Steinman, R., Dorian, P., Hallstrom, A., Cappato, R., Kadish, A.H., Kudenchuk, P.J., Mark, D.B., Inoue, L.Y., Sanders, G.D., Outcomes of implantable cardioverter-defibrillator Use in patients with Comorbidities: results from a Combined analysis of 4 randomized clinical trials. JACC Heart Fail 2 (2014), 623–629.
12. 12 Santangeli, P., Blase, L.D., Russo, A.D., Casella, M., Bartoletti, S., Santarelli, P., Pelargonio, G., Natale, A., Meta-analysis: age and Effectiveness of prophylactic implantable-defibrillators. Ann Intern Med 153 (2010), 592–599.
13. 13 Huang, D.T., Sesselberg, H.W., McNitt, S.M., Noyes, K., Andrews, M.L., Jackson Hall, W., Dick, A., Daubert, J.P., Zareba, W., Moss, A.J., Improved survival Associated with prophylactic defibrillators in elderly patients with prior myocardial infarction and depressed Ventricular Function: a MADITT-II Substudy. J Cardiovasc Electrophysiol 18 (2007), 833–838.
14. 14 Hernandez, A.F., Fonarow, G.C., Hammill, B.G., Al-Khatib, S.M., Yancy, C.W., O'Connor, C.M., Schulman, K.A., Peterson, E.D., Curtis, L.H., Clinical Effectiveness of implantable cardioverter-defibrillators among Medicare Beneficiaries with heart failure. Circ Heart Fail 3 (2010), 7–13.
15. 15 Yuhas, J., Mattocks, K., Gravelin, L., Remetz, M., Foley, J., Fazio, R., Lampert, R., Patients’ attitudes and Perceptions of implantable cardioverter-defibrillators: potential Barriers to appropriate primary prophylaxis. Pacing Clin Electrophysiol 35 (2012), 1179–1187.
16. 16 Fonarow, G.C., Albert, N.M., Curtis, A.B., Stough, W.G., Gheorghiade, M., Heywood, J.T., McBride, M.L., Inge, P.J., Mehra, M.R., O'Connor, C.M., Reynolds, D., Walsh, M.N., Yancy, C.W., Improving Evidence-based care for heart failure in outpatient cardiology practices: primary results of the registry to improve heart failure Therapies in the outpatient Setting (IMPROVE HF.). Circulation 122 (2010), 585–596.
17. 17 Gupta, A., Gholami, P., Turakhia, M.P., Friday, K., Heidenreich, P.A., Clinical reminders to providers of patients with reduced ejection fraction increase defibrillator referral: a randomized trial. Circ Heart Fail 7 (2014), 140–145.
18. 18 Dodson, J.A., Lampert, R., Wang, Y., Hammill, S.C., Varosy, P., Curtis, J.P., Temporal trends in quality of care among Recipients of implantable cardioverter-defibrillators: insights from the national Cardiovascular data registry. Circulation 129 (2014), 580–586.